Elekta (OTCMKTS:EKTAY) Shares Gap Down – Here’s Why

Shares of Elekta AB (OTCMKTS:EKTAY) gapped down before the market opened on Thursday . The stock had previously closed at $5.8650, but opened at $5.53. Elekta shares last traded at $5.53, with a volume of 108 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Elekta presently has a consensus rating of “Reduce”.

Elekta Trading Up 2.4%

The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The stock has a market cap of $2.08 billion, a P/E ratio of -46.91 and a beta of 1.01. The firm’s fifty day moving average price is $5.20 and its two-hundred day moving average price is $5.70.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter. Elekta had a positive return on equity of 13.31% and a negative net margin of 2.38%.The company had revenue of $372.30 million during the quarter. As a group, equities research analysts forecast that Elekta AB will post 0.43 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.